Skip to content
Film Television Auditions – Lifestyle
Author:
Maxona Pharmaceuticals
MAXONA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN MAX-001 CLINICAL TRIAL FOR ACUTE PAIN
November 18, 2026
MAXONA PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FOR ITS PATENT APPLICATION RELATING TO THE USE OF NEFOPAM IN THE TREATMENT OF PRURITUS
October 27, 2026
MAXONA PHARMACEUTICALS RECEIVES FDA IND CLEARANCE FOR MAX-001 PHASE 2 ACUTE PAIN CLINICAL TRIAL
July 15, 2026